ALPHA TEKNOVA, INC. Stock-Based Compensation
ALPHA TEKNOVA, INC. (TKNO) reported Stock-Based Compensation of $1.32 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- ALPHA TEKNOVA, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $622.00K, a 34.53% decline year-over-year.
- ALPHA TEKNOVA, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $695.00K, a 18.43% decline year-over-year.
- ALPHA TEKNOVA, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $777.00K, a 1.44% increase year-over-year.
- ALPHA TEKNOVA, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $850.00K, a 11.84% increase year-over-year.
- ALPHA TEKNOVA, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $3.43M, a 6.46% decline from fiscal 2024.
- ALPHA TEKNOVA, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $3.67M, a 11.39% decline from fiscal 2023.
- ALPHA TEKNOVA, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $4.14M, a 11.48% increase from fiscal 2022.
- ALPHA TEKNOVA, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $3.71M, a 139.26% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $622.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.32M 10-Q · filed 2026-08-06 | $2.09M derived: sum of 3 quarters · filed 2026-08-06 | $2.94M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $695.00K 10-Q · filed 2026-05-07 | $1.47M derived: sum of 2 quarters · filed 2026-05-07 | $2.32M derived: sum of 3 quarters · filed 2026-05-07 | $3.27M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $777.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.63M derived: sum of 2 quarters · filed 2026-03-02 | $2.58M derived: sum of 3 quarters · filed 2026-08-06 | $3.43M 10-K · filed 2026-03-02 |
| 2025-09-30 | $850.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.80M derived: sum of 2 quarters · filed 2026-08-06 | $2.65M 10-Q · filed 2025-11-07 | $3.42M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $950.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.80M 10-Q · filed 2026-08-06 | $2.57M derived: sum of 3 quarters · filed 2026-08-06 | $3.33M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $852.00K 10-Q · filed 2026-05-07 | $1.62M derived: sum of 2 quarters · filed 2026-05-07 | $2.38M derived: sum of 3 quarters · filed 2026-05-07 | $3.21M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $766.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.53M derived: sum of 2 quarters · filed 2026-03-02 | $2.36M derived: sum of 3 quarters · filed 2026-03-02 | $3.67M 10-K · filed 2026-03-02 |
| 2024-09-30 | $760.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.59M derived: sum of 2 quarters · filed 2025-11-07 | $2.90M 10-Q · filed 2025-11-07 | $3.92M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $833.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $2.14M 10-Q · filed 2025-08-08 | $3.16M derived: sum of 3 quarters · filed 2025-08-08 | $4.20M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $1.31M 10-Q · filed 2025-05-09 | $2.33M derived: sum of 2 quarters · filed 2025-05-09 | $3.36M derived: sum of 3 quarters · filed 2025-05-09 | $4.43M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $2.06M derived: sum of 2 quarters · filed 2025-03-07 | $3.13M derived: sum of 3 quarters · filed 2025-03-07 | $4.14M 10-K · filed 2025-03-07 |
| 2023-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $2.10M derived: sum of 2 quarters · filed 2024-11-08 | $3.12M 10-Q · filed 2024-11-08 | $4.14M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $2.08M 10-Q · filed 2024-08-13 | $3.10M derived: sum of 3 quarters · filed 2024-08-13 | $4.07M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $1.01M 10-Q · filed 2024-05-13 | $2.03M derived: sum of 2 quarters · filed 2024-05-13 | $3.00M derived: sum of 3 quarters · filed 2024-05-13 | $3.93M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $1.99M derived: sum of 2 quarters · filed 2024-03-27 | $2.92M derived: sum of 3 quarters · filed 2024-03-27 | $3.71M 10-K · filed 2024-03-27 |
| 2022-09-30 | $968.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.90M derived: sum of 2 quarters · filed 2023-11-13 | $2.69M 10-Q · filed 2023-11-13 | $3.31M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $934.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $1.72M 10-Q · filed 2023-08-11 | $2.35M derived: sum of 3 quarters · filed 2023-08-11 | $2.79M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $787.00K 10-Q · filed 2023-05-11 | $1.41M derived: sum of 2 quarters · filed 2023-05-11 | $1.85M derived: sum of 3 quarters · filed 2023-05-11 | $2.15M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $624.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.07M derived: sum of 2 quarters · filed 2023-03-30 | $1.37M derived: sum of 3 quarters · filed 2023-03-30 | $1.55M 10-K · filed 2023-03-30 |
| 2021-09-30 | $442.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $744.00K derived: sum of 2 quarters · filed 2022-11-14 | $927.00K 10-Q · filed 2022-11-14 | $1.20M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $302.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $485.00K 10-Q · filed 2022-08-11 | $754.00K derived: sum of 3 quarters · filed 2022-08-11 | $785.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $183.00K 10-Q · filed 2022-05-12 | $452.00K derived: sum of 2 quarters · filed 2022-05-12 | $483.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $269.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $300.00K derived: sum of 2 quarters · filed 2022-03-18 | $300.00K 10-K · filed 2022-03-18 | |
| 2020-09-30 | $31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $31.00K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |